Radiopharm Theranostics Limited Research and Development Expense
Radiopharm Theranostics Limited (RDPTF) reported Research and Development Expense of $27.52 million for the 12-month period ending 2025-06-30, per its 20-F filed 2025-09-18.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2025-09-18
| Period end | Research And Development Expense 12 month |
|---|---|
| 2025-06-30 | $27.52M 20-F · filed 2025-09-18 |
| 2024-06-30 | $23.09M 20-F · filed 2025-09-18 |
| 2023-06-30 | $22.63M 20-F · filed 2025-09-18 |